American Well Corp's (NYSE:AMWL) Chief Accounting Officer, Paul Francis McNeice, has recently sold shares in the company, according to a new SEC filing. The transaction, which took place on June 3, 2024, involved the sale of 3,170 shares at a price of $0.4146 per share, totaling over $1,314.
The filing indicated that the sale was executed to cover tax liabilities associated with the vesting of restricted stock units. Specifically, the transaction was described as an automatic "sell to cover" which did not represent a discretionary trade by McNeice. Following this transaction, McNeice still owns 195,281 shares of American Well Corp.
Investors often monitor insider sales as they can provide insights into an executive's perspective on the company's current valuation and future prospects. However, in this case, the sale appears to be a routine financial transaction to fulfill tax obligations rather than a reflection of the executive's outlook on the company's performance.
American Well Corp, a company specializing in business services within the healthcare sector, continues to be a subject of interest for investors who follow insider trading activities for signs of corporate health and individual confidence in the firm's trajectory.
In other recent news, American Well, also known as Amwell, reported a 7% decline in total revenue in the first quarter of 2024, amounting to $59.5 million. Despite this, the company remains focused on expanding its digital care enablement and the success of its Converge platform. Piper Sandler has maintained a neutral stance on Amwell, citing the need for stabilization in subscription revenue and clearer signs of the company's projected return to double-digit growth in 2025.
Amwell's engagement with the Defense Health Agency (DHA) has highlighted its efforts to expand its presence within the healthcare solutions sector, particularly in behavioral health. The firm's neutral rating reflects a wait-and-see approach, requiring further evidence of Amwell's financial performance and growth trajectory.
Looking ahead, Amwell has projected revenue growth and improved adjusted EBITDA for 2025, with revenue expected to be between $335 million and $350 million. The company anticipates gross margins to rise above 50% in the coming years. These recent developments underscore the company's strategic initiatives to capitalize on the evolving digital health market.
InvestingPro Insights
In light of the recent insider transaction at American Well Corp (NYSE:AMWL), investors seeking a deeper understanding of the company's financial health may consider several key metrics and insights from InvestingPro. With a market capitalization of $118.59 million, AMWL holds a notable position within the healthcare business services sector. Despite this, the company's Price/Earnings (P/E) ratio stands at -0.34, with an adjusted P/E ratio for the last twelve months as of Q1 2024 at -0.46, reflecting market skepticism about future earnings.
Moreover, American Well Corp's financial performance has shown some challenges, with a revenue decline of 8.08% over the last twelve months as of Q1 2024. This downward trend is further evidenced by a quarterly revenue growth rate of -7.0% in Q1 2024. Additionally, the company's operating income margin for the same period was -101.85%, indicating that expenses far exceeded the gross profit of $87.88 million.
InvestingPro Tips highlight that while American Well Corp has more cash than debt on its balance sheet, it is quickly burning through cash and is not expected to be profitable this year. Furthermore, the stock has been performing poorly, trading near its 52-week low and exhibiting a significant price drop over the last year, with a one-year total price return of -84.4%. Despite these challenges, the company's liquid assets do exceed its short-term obligations, providing some financial cushion.
For investors interested in a comprehensive analysis, there are additional InvestingPro Tips available for American Well Corp, which can be found at https://www.investing.com/pro/AMWL. These tips can provide further insights into the company's valuation, cash flow, and stock performance. Additionally, investors can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, giving access to an extensive range of professional investment tools and data.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.